January 2 Pharmaceutical market in Russia reached 1.344 trillion rubles in 2016, an increase of 7% over the same period of 2007. The annual sales volume was basically the same as that of 2015, reaching 5.1 billion bales.The market growth mainly comes from the sales of the commercial segment and the retail market Of the sales growth in good shape, mainly from the growth of non-prescription drugs, the current market in the original research and drug sales to reduce the background, the emergence of generic drugs increased the trend.
Another trend in 2016 is the Russian native drug Sales growth and sales and sales of the market share of 29% and 61%, respectively.Pharmaceutical import substitution has been fruitful in recent years, the share of imported drugs decreased year by year, replaced by the growth of locally produced drugs, which have benefited from the ' Limit imports of drugs into the government purchase Act '(' There are two or more local companies bidding and importing companies no longer participate '.) Although local companies are also developing, multinationals still dominate the market, such as Sanofi, Novartis and Bayer.
For the distribution and pharmacy chain markets, there was a trend of increasing concentration in 2016. Russia medicine The distribution area has changed dramatically in the past few years, with three local sales companies filling the top 20 in the past two years, making the top three among the top three companies with a 45% market share in 2015 To 56% in 2016. Competition among the three largest sales companies is also fierce. Protek, number one in terms of sales, accounted for 21.5% of sales, followed by Katren, which was slightly lower, accounting for 21.2%, and the company Пульс grew rapidly in recent years , Accounting for 13.3% share.
In addition, the integration of pharmacy chains has become a major trend in 2016. The independent pharmacy association ASNA achieved the best result in the pharmacy consortium and the pharmacy chain with 4,215 sales outlets, accounting for 7.8% of the market, of which, 36.6pharmacy The highest proportion, reaching 4.7%.
